{"title":"脂肪:减肥手术和程序","authors":"B. McGowan","doi":"10.15277/bjd.2022.368","DOIUrl":null,"url":null,"abstract":"Who would have thought? Surgery as a ‘cure for type 2 diabetes (T2DM)’. I would like to introduce one of my patients, Sarah, a 46year-old woman. She presented 10 years ago, living with obesity (BMI 44) and poorly controlled T2DM. She had been taking insulin for eight years, plus additional GLP-1 agonists and metformin. She underwent several lifestyle interventions for weight loss with little success. She subsequently underwent a Roux-en-Y gastric bypass (RYGB) and was able to come off all insulin and oral antiglycaemic medications. She only takes the recommended multivitamin replacement post-bariatric surgery now. Her HbA1c has been well controlled for several years.","PeriodicalId":42951,"journal":{"name":"British Journal of Diabetes","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fat: bariatric surgery and procedures\",\"authors\":\"B. McGowan\",\"doi\":\"10.15277/bjd.2022.368\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Who would have thought? Surgery as a ‘cure for type 2 diabetes (T2DM)’. I would like to introduce one of my patients, Sarah, a 46year-old woman. She presented 10 years ago, living with obesity (BMI 44) and poorly controlled T2DM. She had been taking insulin for eight years, plus additional GLP-1 agonists and metformin. She underwent several lifestyle interventions for weight loss with little success. She subsequently underwent a Roux-en-Y gastric bypass (RYGB) and was able to come off all insulin and oral antiglycaemic medications. She only takes the recommended multivitamin replacement post-bariatric surgery now. Her HbA1c has been well controlled for several years.\",\"PeriodicalId\":42951,\"journal\":{\"name\":\"British Journal of Diabetes\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2022-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15277/bjd.2022.368\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15277/bjd.2022.368","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Who would have thought? Surgery as a ‘cure for type 2 diabetes (T2DM)’. I would like to introduce one of my patients, Sarah, a 46year-old woman. She presented 10 years ago, living with obesity (BMI 44) and poorly controlled T2DM. She had been taking insulin for eight years, plus additional GLP-1 agonists and metformin. She underwent several lifestyle interventions for weight loss with little success. She subsequently underwent a Roux-en-Y gastric bypass (RYGB) and was able to come off all insulin and oral antiglycaemic medications. She only takes the recommended multivitamin replacement post-bariatric surgery now. Her HbA1c has been well controlled for several years.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
